Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine vs chlorambucil in untreated CLL
CTR20131931Phase 3Active
- Sponsor
- Shandong Lanjin Bioengineering
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bendamustine in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), sponsored by Shandong Lanjin Bioengineering. Started Mar 2014; status: active.
02
Drugs
bendamustine
03
Conditions
chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Beyond the preview
Go deeper on CTR20131931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131931.